Ipsen puts down $20M in $1B deal with Exicure for rare neuro disorders

Retrieved on: 2021-08-02 14:37:30

Tags for this article:

Click the tags to see associated articles and topics

Ipsen puts down $20M in $1B deal with Exicure for rare neuro disorders. View article details on hiswai:

Excerpt

Ipsen is digging deeper into neuroscience, with a $20 million upfront payment to Exicure in a discovery deal for up to two preclinical assets.

Article found on: www.fiercebiotech.com